haloperidol has been researched along with ro 22-1319 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kirkpatrick, B; Tamminga, CA; Thaker, GK; Wagman, AM | 1 |
Kakigi, T; Kaneda, H; Shintani, T; Tanimoto, K; Terada, T | 1 |
Burghardt, B; Kolis, SJ; Mowles, TF; Schwartz, MA; Toome, V; Williams, TH | 1 |
3 other study(ies) available for haloperidol and ro 22-1319
Article | Year |
---|---|
Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
Topics: Adult; Antipsychotic Agents; Brain; Chronic Disease; Dyskinesia, Drug-Induced; Electroencephalography; Haloperidol; Humans; Isoquinolines; Male; Prolactin; Reaction Time; Receptors, Dopamine; Receptors, Dopamine D2; Schizophrenia; Sleep Stages; Sleep, REM; Substance Withdrawal Syndrome | 1989 |
Comparison of prolactin responses to D-1 and D-2 antagonists in rats: Ro 22-1319 is a potent D-2 antagonist.
Topics: Animals; Antipsychotic Agents; Benzazepines; Domperidone; Fluphenazine; Haloperidol; Isoquinolines; Male; Perphenazine; Prolactin; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1989 |
Metabolites of an antipsychotic chiral pyrroloisoquinoline and their effect on prolactin secretion in the rat.
Topics: Animals; Antipsychotic Agents; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Gas Chromatography-Mass Spectrometry; Haloperidol; Isoquinolines; Male; Prolactin; Rats; Structure-Activity Relationship | 1983 |